+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Mycoplasma Testing Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • August 2021
  • Region: Global
  • TechNavio
  • ID: 5025020
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the mycoplasma testing market and it is poised to grow by $ 496.87 mn during 2021-2025, progressing at a CAGR of over 11% during the forecast period. The report on the mycoplasma testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing focus on R&D of biopharmaceuticals, increasing initiatives and funding for mycoplasma testing, and rise in adoption of real-time mycoplasma testing.

The mycoplasma testing market analysis includes product segment and geographic landscape.

The mycoplasma testing market is segmented as below:


By Product

  • Consumables
  • Systems

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing M&A and partnerships between CROs and pharmaceutical and biotechnology companies as one of the prime reasons driving the mycoplasma testing market growth during the next few years. Also, and pharmaceutical and biotechnology companies, increasing healthcare expenditure, and technological advances will lead to sizable demand in the market.

The report on mycoplasma testing market covers the following areas:

  • Mycoplasma testing market sizing
  • Mycoplasma testing market forecast
  • Mycoplasma testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mycoplasma testing market vendors that include Agilent Technologies Inc., Becton Dickinson and Co., Charles River Laboratories International Inc., F. Hoffmann-La Roche Ltd., InvivoGen, Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., and Thermo Fisher Scientific Inc. Also, the mycoplasma testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary

  • Market overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Consumables - Market size and forecast 2020-2025
  • Systems - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Charles River Laboratories International Inc.
  • F. Hoffmann-La Roche Ltd.
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Norgen Biotek Corp.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits

  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Consumables - Market size and forecast 2020-2025 ($ million)
  • Consumables - Year-over-year growth 2020-2025 (%)
  • Systems - Market size and forecast 2020-2025 ($ million)
  • Systems - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share By Geographical Landscape 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Key customers
  • Agilent Technologies Inc. - Segment focus
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Key customers
  • Becton Dickinson and Co. - Segment focus
  • Charles River Laboratories International Inc. - Overview
  • Charles River Laboratories International Inc. - Business segments
  • Charles River Laboratories International Inc. - Key offerings
  • Charles River Laboratories International Inc. - Key customers
  • Charles River Laboratories International Inc. - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • InvivoGen - Overview
  • InvivoGen - Product and service
  • InvivoGen - Key offerings
  • InvivoGen - Key customers
  • InvivoGen - Segment focus
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Key customers
  • Lonza Group Ltd. - Segment focus
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key offerings
  • Merck KGaA - Key customers
  • Merck KGaA - Segment focus
  • Norgen Biotek Corp. - Overview
  • Norgen Biotek Corp. - Product and service
  • Norgen Biotek Corp. - Key offerings
  • Norgen Biotek Corp. - Key customers
  • Norgen Biotek Corp. - Segment focus
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Key customers
  • Thermo Fisher Scientific Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global mycoplasma testing market: Agilent Technologies Inc., Becton Dickinson and Co., Charles River Laboratories International Inc., F. Hoffmann-La Roche Ltd., InvivoGen, Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing M&A and partnerships between CROs and pharmaceutical and biotechnology companies.`

According to the report, one of the major drivers for this market is the increasing focus on R&D of biopharmaceuticals.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Charles River Laboratories International Inc.
  • F. Hoffmann-La Roche Ltd.
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Norgen Biotek Corp.
  • Thermo Fisher Scientific Inc.